In recent years, many studies have found that abnormal expression of long noncoding RNA MALAT1 can be used as a potential biomarker of cancer diagnosis.12, 13 MALAT1 is one of the first identified long noncoding RNA related to post‐transcription modification. This evidence concerns the gene MALAT1 and cancer.